Drug Database
AT

atropine + pralidoxime chloride (Duodote)

✓ Approved

Pfizer, Inc. · CHRM1 · 小分子

什么是 atropine + pralidoxime chloride?

atropine + pralidoxime chloride 是一种小分子,由Pfizer, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名Duodote
公司Pfizer, Inc.
药物类别小分子
分子靶点CHRM1, CHRM2, CHRM3, CHRM4
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

作用机制

分子靶点

atropine + pralidoxime chloride 作用于 4 个分子靶点:

CHRM1cholinergic receptor muscarinic 1 (M1, HM1)
CHRM2cholinergic receptor muscarinic 2 (HM2)
CHRM3cholinergic receptor muscarinic 3 (HM3, PBS)
CHRM4cholinergic receptor muscarinic 4 (HM4, M4R)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

atropine + pralidoxime chloride 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Injury, poisoning and procedural complicationsChemical poisoning✓ Approved

相关研究文献

PubMedNature communications2026-11-19

Orbital coupling effect enables low-chloride concentration electrolyte for four-electron redox in aqueous zinc | |iodine batteries.

Wang Shuai S, Wang Haoran H, So Mei Yi MY, Han Jing J et al.

The I-/I0/I+ redox chemistry is hindered by the inherent instability of the electrophilic I+, which undergoes hydrolysis in aqueous media or is rapidly consumed by comproportionation with triiodide ions. Here, we design a copper single-atom embedded nitrogen-doped carbon host that synergistically combines d-p orbital hybridization and local low-concentration chloride ions to stabilize the I+. The atomic Cu-Nx sites interact moderately with iodine species through Cu d- and I p-orbital hybridization, which enhances iodine species adsorption, accelerates redox kinetics, and increases the hydrolysis energy barrier of I+. Simultaneously, the Cu-Nx sites promote a localized I-Cl microenvironment through electrostatic interaction, enabling efficient I0/I+ conversion even in a low-concentration Cl- ion electrolyte. As a result, the assembled zinc | |iodine battery exhibits a distinct four-electron dual-voltage plateau, achieving a high capacity of ~408 mAh g-1 at 1 A g-1. Even at a high specific current of 10 A g-1, the cell exhibits a high initial capacity of ~251 mAh g-1 and maintains a capacity retention of 70% with a low decay rate of 0.0062‰ per cycle over 50,000 cycles. This work provides a rational design method for coupling single-atom catalysis with localized ion confinement to realize high-voltage and long-life iodine conversion chemistry.

PMID 43052287
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

A Cationic Ruthenium Olefin Metathesis Catalyst Supported on Weakly Coordinating Silica.

Kling Maximillian M, Verma Vikas V, Rodriguez Jessica J, Mayer Jacob J et al.

Silica functionalized with Lewis acidic silylium aluminate ion-pairs ([iPr3Si][(RFO)3Al-OSi≡] (RF = C(CF3)3)) abstract chloride from the second-generation Grubbs-Hoveyda catalyst (SIMes)Cl2Ru=CH(o-iPrO-C6H4) (GH-II) to form supported [(SIMes)ClRu=CH(o-iPrO-C6H4)][(RFO)3Al-OSi≡] (1) and iPr3SiCl. Solid-state NMR measurements at 100 K, desorption of Ru from the support, and X-ray adsorption spectroscopy (XAS) are consistent with formation of a monomeric Ru-benzylidene cation that is electrostatically immobilized on the modified silica surface. 1 is active and selective in ring closing metathesis (RCM), self-metathesis, ring opening metathesis polymerization (ROMP), acyclic diene metathesis (ADMET), cross metathesis, and ethenolysis reactions. 1 is generally more active than cationic [(SIMes)ClRu=CH(o-iPrO-C6H4)]2[BArF4]2 (GH-II+; BArF4 = tetrakis(3,5-bis(trifluoromethyl)phenyl)borate) in these reactions and gives higher yields with higher selectivity than neutral GH-II under equivalent conditions. DFT calculations comparing models of GH-II+ and 1 suggest that cationic Ru=CH2+ is stabilized by interactions with the anion and accounts for the increase in reaction rates observed using 1 compared to GH-II+.

PMID 43053426
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Ultrastretchable, Tissue-Matched Piezoelectric Gel with Preferentially Oriented Molecular Ferroelectric Crystallization.

Chen Hao-Ran HR, Zhang Yu-Hao YH, Ding Lei L, Li Jun-Yi JY et al.

Molecular ferroelectrics hold great potential for bioelectronics because of their excellent piezoelectric responses and biocompatibility. However, conventional integration into gel matrices suffers from two major drawbacks: solvent evaporation methods often yield brittle films with poor modulus matching with soft tissues, whereas physical blending typically leads to filler agglomeration and random crystal dispersion, making it difficult to achieve preferential crystal orientation and thereby limiting the piezoelectric performance. Here, we report an in situ crystallization strategy assisted by solvent exchange. This approach enables preferentially oriented triglycine sulfate (TGS) crystals to form within a polyacrylamide (PAM) network reinforced by glycidyl methacrylate-grafted bovine serum albumin (B-G). The B-G macromer strengthens the network through covalent integration and reversible hydrogen-bonding interactions. Subsequent treatment with a choline chloride/sorbitol deep eutectic solvent (DES) induced the preferential orientation of TGS within the gel matrix. The resulting gel achieved a fracture strain exceeding 2800%, maintained mechanical integrity over 10000 loading-unloading cycles, and exhibited mechanical compliance within the range of human soft tissues (10-5-10-4 Pa-1). In vitro and in vivo evaluations further demonstrated favorable biocompatibility and its potential for flexible piezoelectric sensing applications. This work provides molecular-level insight into the design of highly conformable piezoelectric gels containing preferentially oriented molecular ferroelectrics for tissue-matched biointerfaces.

PMID 43053447
阅读全文 →
PubMedJournal of translational medicine2026-11-18

From predicting myopia progression to identifying treatment benefit: interpreting choroidal remodeling during atropine therapy.

Chen Jing J

PMID 43046242
阅读全文 →
PubMedACS chemical neuroscience2026-11-18

Advances in Fluorescent Probes to Illuminate Chloride Dynamics in the Brain.

Rahmani Cahya C, Lim Hyun-Ho HH, Alamudi Samira Husen SH

Chloride ions (Cl-) play an important role in regulating neuronal excitability, inhibitory neurotransmission, cell volume control, and ionic homeostasis in the brain. Precise control of the intracellular chloride concentration is essential for normal neuronal and glial function, while its dysregulation has been linked to neurological disorders such as epilepsy, neurodevelopmental disorders, schizophrenia, and neurodegenerative diseases. Therefore, understanding chloride dynamics has become an essential step in neuroscience research. To further support the observation of chloride dynamics, fluorescence imaging has emerged as a powerful approach for monitoring intracellular chloride in living cells, offering high spatial and temporal resolution that complements conventional electrophysiological techniques. This review provides an overview of the significance of chloride dynamics in the nervous system and discusses fluorescence-based strategies for investigating chloride homeostasis. The development of fluorescent chloride probes is summarized, from early small-molecule dyes to genetically encoded fluorescent proteins with emphasis on their sensing mechanisms, advantages, limitations, and applications. Finally, current challenges and future directions in probe development, including improved chloride selectivity, reduced pH sensitivity, and subcellular targeting, are discussed.

PMID 43046854
阅读全文 →
PubMedNPJ digital medicine2026-11-18

A flexible wearable system for integrated sweat stimulation and chloride analysis in cystic fibrosis diagnosis.

Zhou Mingyu M, Yang Da Som DS, Kim Joohee J, Kim Jae-Hwan JH et al.

Cystic Fibrosis (CF) diagnosis relies on quantitative sweat chloride testing, a process that requires highly trained personnel, bulky instrumentation, and a cumbersome workflow performed at specialized clinical centers with high per-test cost. Recent advances in wearable sweat biomarker sensors offer opportunities for the development of point-of-care CF sweat chloride analysis. This work presents a flexible, wearable platform for sweat chloride testing, based on miniaturized, automated iontophoresis stimulation, microfluidic sweat collection, and colorimetric chloride analysis. This system enables quantitative, visually interpretable chloride measurements without external instrumentation, requires only microliters of sweat to operate, and reduces the per-test cost to around 1 dollar. Clinical evaluation of the device with 55 subjects at a single pediatric CF center demonstrates strong agreement between chloride concentrations from standard-of-care sweat testing and this platform, with reliable operation across physiologically relevant chloride concentrations. This platform provides a practical, scalable alternative for CF diagnosis in a range of clinical settings with potential for use in the home.

PMID 43045720
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多atropine + pralidoxime chloride